Identification of Natural Products Inhibiting SARS-CoV-2 by Targeting Viral Proteases: A Combined in Silico and in Vitro Approach
Andreas Wasilewicz(University of Vienna), Judith M. Rollinger(University of Vienna), Benjamin Kirchweger(University of Vienna), Julien Orts(ETH Zurich), Matthias Bütikofer(ETH Zurich), Julia Langeder(University of Vienna), Léonardo Scapozza(University of Geneva), Olivier Petermann(University of Geneva), Jindřich Činátl(Goethe University Frankfurt), Johannes Kirchmair(Niigata University of Pharmacy and Medical and Life Sciences), Ulrike Grienke(Universität Innsbruck), Marie Jose Abi Saad(University of Vienna), Sigrid Adelsberger(University of Vienna), Holger F. Rabenau(Institute of Virology of the Slovak Academy of Sciences), Denisa Bojková(Goethe University Frankfurt)
Cited by 33
Related Papers
Natural products in drug discovery: advances and opportunities
|Nature Reviews Drug Discovery|2021|5.2k
Identification of a Novel Coronavirus in Patients with Severe Acute Respiratory Syndrome
|New England Journal of Medicine|2003|4.8k
Discovery and resupply of pharmacologically active plant-derived natural products: A review
|Biotechnology Advances|2015|2.9k
Natural product agonists of peroxisome proliferator-activated receptor gamma (PPARγ): a review
|Biochemical Pharmacology|2014|593
Predicting drug metabolism: experiment and/or computation?
|Nature Reviews Drug Discovery|2015|500